Outcomes Network Graph
Outcomes Flow Chart
User reported effectiveness ratings Amitriptyline (Elavil) for various conditions.
|Conditions||Major Improvement||Moderate Improvement||Much Worse||No Effect||Worse||Responses|
|Chronic Fatigue Syndrome||1%||27%||23%||22%||27%||100|
|Irritable Bowel Syndrome||7%||18%||7%||56%||11%||55|
Below is the degree of change seen after Amitriptyline (Elavil) is higher than average.
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Average by Year
Average by Month
Average by Day of Week
Below is the change in the listed outcome after is higher than average.
(Math.abs(a['change']) < Math.abs(b['change'])) ? 1 : -1)" title="Click to put the results with the largest observed change at the top"> Sort by Effect Size
(a['number_of_days'] < b['number_of_days']) ? 1 : -1)" title="Click to put the results with the most supporting data points at the top."> Sort by Confidence
Amitriptyline (Elavil) Info
|Variable Name||Amitriptyline (Elavil)|
|Analysis Performed At||2020-10-09|
|Duration of Action||21 days|
|Minimum Allowed Value||0 count|
|Number of Aggregate Predictors||0|
|Number of Aggregate Outcomes||9|
|Number of Measurements||1|
|Number of Measurements (including those generated by tagged, joined, or child variables)||1|
|Onset Delay||30 minutes|